Hoppa till huvudinnehåll

growth differentiation factor 3

The GDF3 gene provides instructions for making a protein that is part of the transforming growth factor beta (TGFβ) superfamily, which is a group of proteins that help control the growth and development of tissues throughout the body. Within the TGFβ superfamily, the GDF3 protein belongs to the bone morphogenetic protein family, which helps regulate the growth and maturation (differentiation) of bone and cartilage. Cartilage is a tough but flexible tissue that makes up much of the skeleton during early development. The proteins in this family help regulate cell growth and differentiation both before and after birth. While the GDF3 protein is known to be involved in bone and cartilage development, its exact role is unclear.

Videoval för Genes
Videobibliotek

Normal function

The GDF3 gene provides instructions for making a protein that is part of the transforming growth factor beta (TGFβ) superfamily, which is a group of proteins that help control the growth and development of tissues throughout the body. Within the TGFβ superfamily, the GDF3 protein belongs to the bone morphogenetic protein family, which helps regulate the growth and maturation (differentiation) of bone and cartilage. Cartilage is a tough but flexible tissue that makes up much of the skeleton during early development. The proteins in this family help regulate cell growth and differentiation both before and after birth. While the GDF3 protein is known to be involved in bone and cartilage development, its exact role is unclear.

The GDF3 protein is also involved in the development of the eyes, specifically the specialized light-sensitive tissue that lines the back of the eye called the retina.

Conditions referring to this gene or chromosome

Other names

GDF-3

growth/differentiation factor 3

Related patient information and medicines

Halscancer

Patient information leaflet

Halscancer

(The throat is usually spr... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. To confirm the diagnosis If anything suspicious is seen by the.

Peniscancer

Patient information leaflet

Peniscancer

Den exact reason why a cell becomes cancerous is un. It is thought that something damages or alters certain genes in the cell. By looking at certain features of the cells under the ... Grade 1 (low grade) - the cells look reasonably similar to normal cells. The cancer cells are said to be 'well differentiated'. Grade 2 - is a middle grade. Grade 3.

Diabetisk retinopati

Patient information leaflet

Diabetisk retinopati

New abnormal blood ... This is called proliferative retinopathy. These new vessels are delicate and can bleed easily. There are signs of blood flow becoming restricted but not yet showing new blood vessels growing (see below). Stage 3: proliferative retinopathy Proliferative retinopathy is the advanced diabetic retinopathy that occurs when damaged.

Bröstcancer

Patient information leaflet

Bröstcancer

Breast cancer is the most common cancer in women. What is breast cancer? | Patient Explainers Breast cancer is the most common cancer in women. Find out more: [/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet) Follow Patient: Website: [/](https://patient.info/) Facebook:.

Akromegali

Patient information leaflet

Akromegali

Akromegali is a rare, progressive condition in which you make too much growth hormone. This causes a range of symptoms that develop gradually, often over several years. The most noticeable symptoms are that your hands and feet become larger and features of your face may become more prominent. The cause is usually a small non-cancerous growth.

Högt blodtryck under graviditeten

Patient information leaflet

Högt blodtryck under graviditeten

Developing chronic hypertension in later life. The risks to your baby include: An increased chance of poor growth and a low birth weight. An increased chance of premature birth Premature labour. You may be offered a placental growth factor blood test to help rule out pre-eclampsia between 20 weeks och up till 35 weeks of pregnancy, if you are.

Artikelhistorik

Informationen på denna sida är skriven och granskad av kvalificerade kliniker.
  • 30 sep 2025 | Senaste versionen
  • 1 Sept 2025 | Ursprungligen publicerad

Delta i konversationen

Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.

Ansvarsfriskrivning: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Onlineapotek, behandlingar och hälsotjänster

Enkel tillgång till pålitliga behandlingar och hälsotjänster online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Anmäl dig till Patientens nyhetsbrev

Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.

Vänligen ange en giltig e-postadress

Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.